Inhibitors of extracellular signal-regulated kinase
US-2025353826-A1 · Nov 20, 2025 · US
This page is not indexed by search engines while we improve data quality.
Mackerell Jr Alexander D patents
Mackerell Jr Alexander D is listed as an inventor on 29 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Mackerell Jr Alexander D |
| Total patents | 29 |
| First publication | Aug 25, 2015 |
| Latest publication | Nov 20, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
Inhibitors of extracellular signal-regulated kinase
US-12404259-B2 · Sep 2, 2025 · US
Inhibitors of extracellular signal-regulated kinase
US-2025129038-A1 · Apr 24, 2025 · US
NON-ATP/CATALYTIC SITE p38 MITOGEN ACTIVATED PROTEIN KINASE INHIBITORS
US-2025100985-A1 · Mar 27, 2025 · US
Non-ATP/catalytic site p38 mitogen activated protein kinase inhibitors
US-12202810-B2 · Jan 21, 2025 · US
NON-CATALYTIC SUBSTRATE-SELECTIVE p38alpha-SPECIFIC MAPK INHIBITORS WITH ENDOTHELIAL-STABILIZING AND ANTI-INFLAMMATORY ACTIVITY, AND METHODS OF USE THEREOF
US-2024366619-A1 · Nov 7, 2024 · US
Broad spectrum antiviral compounds targeting the ski complex
US-2024132484-A1 · Apr 25, 2024 · US
Non-catalytic substrate-selective p38α-specific MAPK inhibitors with endothelial-stabilizing and anti-inflammatory activity, and methods of use thereof
US-11911392-B2 · Feb 27, 2024 · US
Non-catalytic substrate-selective p38alpha-specific MAPK inhibitors with endothelial-stabilizing and anti-inflammatory activity, and methods of use thereof
US-11911393-B2 · Feb 27, 2024 · US
Non-ATP/catalytic site p38 Mitogen Activated Protein Kinase inhibitors
US-11718595-B2 · Aug 8, 2023 · US
Recent patents
Latest publications not already listed above.
NON-CATALYTIC SUBSTRATE-SELECTIVE p38alpha-SPECIFIC MAPK INHIBITORS WITH ENDOTHELIAL-STABILIZING AND ANTI-INFLAMMATORY ACTIVITY, AND METHODS OF USE THEREOF
US-2023201211-A1 · Jun 29, 2023 · US
RUNX2 transcription factor inhibitors and uses thereof
US-11634381-B2 · Apr 25, 2023 · US
NON-CATALYTIC SUBSTRATE-SELECTIVE p38alpha-SPECIFIC MAPK INHIBITORS WITH ENDOTHELIAL-STABILIZING AND ANTI-INFLAMMATORY ACTIVITY, AND METHODS OF USE THEREOF
US-2022331329-A1 · Oct 20, 2022 · US
Non-catalytic substrate-selective, p38α-specific MAPK inhibitors with endothelial-stabilizing and anti-inflammatory activity, and methods of use thereof
US-11357781-B2 · Jun 14, 2022 · US
NON-ATP/CATALYTIC SITE p38 MITOGEN ACTIVATED PROTEIN KINASE INHIBITORS
US-2021317097-A1 · Oct 14, 2021 · US
Non-catalytic substrate-selective, p38alpha-specific mapk inhibitors with endothelial-stabilizing and anti-inflammatory activity, and methods of use thereof
US-2021267987-A1 · Sep 2, 2021 · US
Non-ATP/catalytic site p38 mitogen activated protein kinase inhibitors
US-11078171-B2 · Aug 3, 2021 · US
NON-ATP/CATALYTIC SITE p38 MITOGEN ACTIVATED PROTEIN KINASE INHIBITORS
US-2020331874-A1 · Oct 22, 2020 · US
RUNX2 Transcription Factor Inhibitors and Uses Thereof
US-2019263751-A1 · Aug 29, 2019 · US
NON-CATALYTIC SUBSTRATE-SELECTIVE P38alpha-SPECIFIC MAPK INHIBITORS WITH ENDOTHELIAL-STABILIZING AND ANTI-INFLAMMATORY ACTIVITY, AND METHODS OF USE THEREOF
US-2019151324-A1 · May 23, 2019 · US
Methods and systems for organic solute sampling of aqueous and heterogeneous environments
US-2018373846-A1 · Dec 27, 2018 · US
Method for binding site identification by molecular dynamics simulation (silcs: site identification by ligand competitive saturation)
US-2018300447-A1 · Oct 18, 2018 · US
Method for binding site identification by molecular dynamics simulation (silcs: site identification by ligand competitive saturation)
US-10002228-B2 · Jun 19, 2018 · US
LRRK2 GTP binding inhibitors for treatment of Parkinson's disease and neuroinflammatory disorders
US-9701627-B2 · Jul 11, 2017 · US
Methods and systems for organic solute sampling of aqueous and heterogeneous environments
US-2016357945-A1 · Dec 8, 2016 · US
Defensin-like molecules as novel antimicrobial agents
US-9351963-B2 · May 31, 2016 · US
Method for binding site identification by molecular dynamics simulation (silcs: site identification by ligand competitive saturation)
US-2016070850-A1 · Mar 10, 2016 · US
Lrrk2 gtp binding inhibitors for treatment of parkinson's disease and neuroinflammatory disorders
US-2015361038-A1 · Dec 17, 2015 · US
Non-ATP dependent inhibitors of extracellular signal-regulated kinase (ERK)
US-9115122-B2 · Aug 25, 2015 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Univ Maryland | 29 |
| Us Veterans Affairs | 10 |
| Gen1E Lifesciences Inc | 3 |
| Shapiro Paul S | 1 |
| Mackerell Jr Alexander D | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P35/00 | 19 |
| A61P29/00 | 11 |
| A61P11/00 | 11 |
| C07D213/81 | 9 |
| C07D413/12 | 9 |